ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Tobacco leaves enlisted for speedy flu vaccine production

OSAKA -- Mitsubishi Tanabe Pharma is developing a process that uses tobacco leaves to produce influenza vaccines within one month -- a sixth of the time typically needed.

     The technique will be put into commercial use as soon as fiscal 2018 or 2019. Mitsubishi Tanabe has all but finished verifying the safety and effectiveness of the vaccines in the U.S. and Canada. The inoculations are set to undergo final clinical trials in the U.S. by the end of this year.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more